Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

We have limited Spanish content available. View Spanish content.

Snap Chart

Where Big Pharma Is Placing Its Digital Bets

Leaders are investing heavily in digital therapeutics, electronic medical records and diagnostics.

Snap Chart

Where Big Pharma Is Placing Its Digital Bets
en

Leading pharma companies are turning to big data, machine learning and analytics to reduce the time and cost of clinical trials and to bring new drugs to market faster. But many companies feel frustrated by their efforts to deploy data and analytics, according to a recent Bain & Company survey. New solutions require companies to modernize data pipelines and data architecture.

Christoph Schlegel and Reynold Strossen are partners with Bain & Company’s Healthcare practice. Christoph is based in the firm’s Frankfurt office; Reynold is located in the New York office.

Related Brief

A Smarter Way for Healthcare Companies to Go Digital

Start building a trove of high-quality data and a business model that puts it to work.

Tags

Ready to talk?

We work with ambitious leaders who want to define the future, not hide from it. Together, we achieve extraordinary outcomes.